The Methylation Effect in Medicinal Chemistry

被引:767
作者
Barreiro, Eliezer J. [1 ,2 ,3 ]
Kuemmerle, Arthur E. [1 ,3 ]
Fraga, Carlos A. M. [1 ,2 ,3 ]
机构
[1] Univ Fed Rio de Janeiro, Fac Farm, Lab Avaliacao & Sintese Subst Bioat LASSBio, CCS, BR-21941902 Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Farmacol & Quim Med, BR-21941902 Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Inst Quim, Programa Posgrad Quim, BR-21941902 Rio De Janeiro, Brazil
关键词
HMG-COA REDUCTASE; GASTRIC-ACID-SECRETION; TYROSINE KINASE INHIBITOR; PROTON-PUMP INHIBITOR; COENZYME-A REDUCTASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; THYMIDYLATE SYNTHASE INHIBITORS; PHENYLAMINO-PYRIMIDINE PAP; IN-VITRO METABOLISM; GROWTH-FACTOR;
D O I
10.1021/cr200060g
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The importance of the simple methyl group as a very useful structural modification in the rational design of bioactive compounds and drugs is examined. The methyl effect alters both biological phases of a drug, represented by its pharmacodynamic and pharmacokinetc profile, due to the modifications introduced in the stereoeletronic properties. Cimetidine contains an imidazolyl nucleus and a methyl group at C-5, thus favoring the tautomeric form necessary for H 2 receptor selectivity. The thioether in the side chain of cimetidine ensured adequate hydrophobic properties and led to increased selective antagonist activity. The activation mechanism of proton pump inhibitors (PPI) is directly related to the nitrogen nucleophilicity of the pyridine moiety, which depends on the electronic effect of substituents on the pKa of the pyridine ring. When electron-donating substituent, such as methyl groups are attached to the pyridine ring then its pKa increases, thus increasing its protonation rate at any given pH.
引用
收藏
页码:5215 / 5246
页数:32
相关论文
共 328 条
[91]   INHIBITION OF CHOLESTEROL-SYNTHESIS INVITRO AND INVIVO BY ML-236A AND ML-236B, COMPETITIVE INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE [J].
ENDO, A ;
TSUJITA, Y ;
KURODA, M ;
TANZAWA, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1977, 77 (01) :31-36
[92]   RESOLUTION OF THE ENANTIOMERS OF OMEPRAZOLE AND SOME OF ITS ANALOGS BY LIQUID-CHROMATOGRAPHY ON A TRISPHENYLCARBAMOYLCELLULOSE-BASED STATIONARY PHASE - THE EFFECT OF THE ENANTIOMERS OF OMEPRAZOLE ON GASTRIC GLANDS [J].
ERLANDSSON, P ;
ISAKSSON, R ;
LORENTZON, P ;
LINDBERG, P .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 532 (02) :305-319
[93]   Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2 [J].
Esser, R ;
Berry, C ;
Du, ZM ;
Dawson, J ;
Fox, A ;
Fujimoto, RA ;
Haston, W ;
Kimble, EF ;
Koehler, J ;
Peppard, J ;
Quadros, E ;
Quintavalla, J ;
Toscano, K ;
Urban, L ;
van Duzer, J ;
Zhang, XL ;
Zhou, SY ;
Marshall, PJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2005, 144 (04) :538-550
[94]   The role of permeability in drug ADME/PK, interactions and toxicity - Presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans [J].
Fagerholm, Urban .
PHARMACEUTICAL RESEARCH, 2008, 25 (03) :625-638
[95]   RIBOFLAVIN DEFICIENCY AND IRON-ABSORPTION IN ADULT GAMBIAN MEN [J].
FAIRWEATHERTAIT, SJ ;
POWERS, HJ ;
MINSKI, MJ ;
WHITEHEAD, J ;
DOWNES, R .
ANNALS OF NUTRITION AND METABOLISM, 1992, 36 (01) :34-40
[96]  
Farber E, 1969, EVOLUTION CHEM
[97]   SUBSTITUTED BENZIMIDAZOLES INHIBIT GASTRIC-ACID SECRETION BY BLOCKING (H++K+)ATPASE [J].
FELLENIUS, E ;
BERGLINDH, T ;
SACHS, G ;
OLBE, L ;
ELANDER, B ;
SJOSTRAND, SE ;
WALLMARK, B .
NATURE, 1981, 290 (5802) :159-161
[98]   COX-2 and beyond: Approaches to prostaglandin inhibition in human disease [J].
FitzGerald, G .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (11) :879-890
[99]  
FLOYD MB, 1975, PROSTAGLANDINS, V10, P289
[100]  
FREDHOLM BB, 1994, PHARMACOL REV, V46, P143